Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer

Hyun Jik Lee, Wan Park, Hyuk Lee, Keun Ho Lee, Jun Chul Park, Sung Kwan Shin, SangKil Lee, Yongchan Lee, Sung Hoon Noh

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aims: The aim of this study was to evaluate the outcome of endoscopic dilation for benign anastomotic stricture after radical gastrectomy in gastric cancer patients. Methods: Gastric cancer patients who underwent endoscopic balloon dilation for benign anastomosis stricture after radical gastrectomy during a 6-year period were reviewed retrospectively. Results: Twenty-one patients developed benign strictures at the site of anastomosis. The majority of strictures occurred within 1 year after surgery (95.2%). The median duration to stenosis after surgery was 1.70 months (range, 0.17 to 23.97 months). The success rate of the first endoscopic dilation was 61.9%. Between the restenosis group (n=8) and the no restenosis group (n=13), there were no significant differences in the body mass index (22.82 kg/ m2 vs 22.46 kg/m2), interval to symptom onset (73.9 days vs 109.3 days), interval to treatment (84.6 days vs 115.6 days), maximal balloon diameter (14.12 mm vs 15.62 mm), number of balloon dilation sessions (1.75 vs 1.31), location of gastric cancer or type of surgery. One patient required surgery because of stricture refractory to repeated dilation. Conclusions: Endoscopic dilation is a highly effective treatment for benign anastomotic strictures after radical gastrectomy for gastric cancer and should be considered a primary intervention prior to proceeding with surgical revision.

Original languageEnglish
Pages (from-to)394-399
Number of pages6
JournalGut and Liver
Volume8
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Gastrectomy
Endoscopy
Stomach Neoplasms
Dilatation
Pathologic Constriction
Reoperation
Body Mass Index
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Lee, H. J., Park, W., Lee, H., Lee, K. H., Park, J. C., Shin, S. K., ... Noh, S. H. (2014). Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer. Gut and Liver, 8(4), 394-399. https://doi.org/10.5009/gnl.2014.8.4.394
Lee, Hyun Jik ; Park, Wan ; Lee, Hyuk ; Lee, Keun Ho ; Park, Jun Chul ; Shin, Sung Kwan ; Lee, SangKil ; Lee, Yongchan ; Noh, Sung Hoon. / Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer. In: Gut and Liver. 2014 ; Vol. 8, No. 4. pp. 394-399.
@article{d1c1219d53b34a5882f58427a2260037,
title = "Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer",
abstract = "Background/Aims: The aim of this study was to evaluate the outcome of endoscopic dilation for benign anastomotic stricture after radical gastrectomy in gastric cancer patients. Methods: Gastric cancer patients who underwent endoscopic balloon dilation for benign anastomosis stricture after radical gastrectomy during a 6-year period were reviewed retrospectively. Results: Twenty-one patients developed benign strictures at the site of anastomosis. The majority of strictures occurred within 1 year after surgery (95.2{\%}). The median duration to stenosis after surgery was 1.70 months (range, 0.17 to 23.97 months). The success rate of the first endoscopic dilation was 61.9{\%}. Between the restenosis group (n=8) and the no restenosis group (n=13), there were no significant differences in the body mass index (22.82 kg/ m2 vs 22.46 kg/m2), interval to symptom onset (73.9 days vs 109.3 days), interval to treatment (84.6 days vs 115.6 days), maximal balloon diameter (14.12 mm vs 15.62 mm), number of balloon dilation sessions (1.75 vs 1.31), location of gastric cancer or type of surgery. One patient required surgery because of stricture refractory to repeated dilation. Conclusions: Endoscopic dilation is a highly effective treatment for benign anastomotic strictures after radical gastrectomy for gastric cancer and should be considered a primary intervention prior to proceeding with surgical revision.",
author = "Lee, {Hyun Jik} and Wan Park and Hyuk Lee and Lee, {Keun Ho} and Park, {Jun Chul} and Shin, {Sung Kwan} and SangKil Lee and Yongchan Lee and Noh, {Sung Hoon}",
year = "2014",
month = "1",
day = "1",
doi = "10.5009/gnl.2014.8.4.394",
language = "English",
volume = "8",
pages = "394--399",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "4",

}

Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer. / Lee, Hyun Jik; Park, Wan; Lee, Hyuk; Lee, Keun Ho; Park, Jun Chul; Shin, Sung Kwan; Lee, SangKil; Lee, Yongchan; Noh, Sung Hoon.

In: Gut and Liver, Vol. 8, No. 4, 01.01.2014, p. 394-399.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer

AU - Lee, Hyun Jik

AU - Park, Wan

AU - Lee, Hyuk

AU - Lee, Keun Ho

AU - Park, Jun Chul

AU - Shin, Sung Kwan

AU - Lee, SangKil

AU - Lee, Yongchan

AU - Noh, Sung Hoon

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background/Aims: The aim of this study was to evaluate the outcome of endoscopic dilation for benign anastomotic stricture after radical gastrectomy in gastric cancer patients. Methods: Gastric cancer patients who underwent endoscopic balloon dilation for benign anastomosis stricture after radical gastrectomy during a 6-year period were reviewed retrospectively. Results: Twenty-one patients developed benign strictures at the site of anastomosis. The majority of strictures occurred within 1 year after surgery (95.2%). The median duration to stenosis after surgery was 1.70 months (range, 0.17 to 23.97 months). The success rate of the first endoscopic dilation was 61.9%. Between the restenosis group (n=8) and the no restenosis group (n=13), there were no significant differences in the body mass index (22.82 kg/ m2 vs 22.46 kg/m2), interval to symptom onset (73.9 days vs 109.3 days), interval to treatment (84.6 days vs 115.6 days), maximal balloon diameter (14.12 mm vs 15.62 mm), number of balloon dilation sessions (1.75 vs 1.31), location of gastric cancer or type of surgery. One patient required surgery because of stricture refractory to repeated dilation. Conclusions: Endoscopic dilation is a highly effective treatment for benign anastomotic strictures after radical gastrectomy for gastric cancer and should be considered a primary intervention prior to proceeding with surgical revision.

AB - Background/Aims: The aim of this study was to evaluate the outcome of endoscopic dilation for benign anastomotic stricture after radical gastrectomy in gastric cancer patients. Methods: Gastric cancer patients who underwent endoscopic balloon dilation for benign anastomosis stricture after radical gastrectomy during a 6-year period were reviewed retrospectively. Results: Twenty-one patients developed benign strictures at the site of anastomosis. The majority of strictures occurred within 1 year after surgery (95.2%). The median duration to stenosis after surgery was 1.70 months (range, 0.17 to 23.97 months). The success rate of the first endoscopic dilation was 61.9%. Between the restenosis group (n=8) and the no restenosis group (n=13), there were no significant differences in the body mass index (22.82 kg/ m2 vs 22.46 kg/m2), interval to symptom onset (73.9 days vs 109.3 days), interval to treatment (84.6 days vs 115.6 days), maximal balloon diameter (14.12 mm vs 15.62 mm), number of balloon dilation sessions (1.75 vs 1.31), location of gastric cancer or type of surgery. One patient required surgery because of stricture refractory to repeated dilation. Conclusions: Endoscopic dilation is a highly effective treatment for benign anastomotic strictures after radical gastrectomy for gastric cancer and should be considered a primary intervention prior to proceeding with surgical revision.

UR - http://www.scopus.com/inward/record.url?scp=84903689138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903689138&partnerID=8YFLogxK

U2 - 10.5009/gnl.2014.8.4.394

DO - 10.5009/gnl.2014.8.4.394

M3 - Article

C2 - 25071904

AN - SCOPUS:84903689138

VL - 8

SP - 394

EP - 399

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 4

ER -